Navigation Links
Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis
Date:7/7/2009

DALLAS, July 7 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today new preclinical data demonstrating that thiarabine shows remarkable efficacy in the prevention and treatment of rheumatoid arthritis (RA). In a well-established animal model for RA, an exceptional restoration of joint structure was observed in the studies, which were conducted at Wayne State University School of Medicine and at Southern Research Institute.

As a therapeutic treatment of established disease, thiarabine demonstrated a highly significant, dose-dependent amelioration of arthritis. Thiarabine treatment resulted in a broad inhibition of disease pathology, with reduction of both inflammatory and erosive disease parameters, as well as protection from loss of cartilage matrix proteins. When used as a preventative treatment, thiarabine blocked the development of joint disease at the 60 mg/kg/day dose level and exhibited a significant reduction in disease incidence and severity at 20 mg/kg/day.

In a therapeutic study comparing thiarabine to methotrexate, a commonly used clinical drug for RA treatment, high resolution 3-D images from an X-ray microtomograph were used along with histological scoring to evaluate joint and bone destruction. Thiarabine demonstrated statistically significant anti-arthritic efficacy comparable to that of methotrexate. "The images from X-ray microtomography present a compelling visual representation of diseased vs. treated limbs" commented David Nowotnik, Senior Vice President Research and Development. "We are delighted with the results of the preclinical study which demonstrate a real benefit to the use of thiarabine in RA."

"Our current development focus for thiarabine is for the treatment of hematological cancers," stated Jeffrey B. Davis, President & CEO. "But
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
2. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
3. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
4. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
5. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
6. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
7. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
8. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
9. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
10. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
11. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013  Sinovac Biotech Ltd. (NASDAQ: ... biopharmaceutical products in China , ... company of Sinovac, obtained the Certificate of Good ... the China State and Food Administration (CFDA) for ... plants, and its Changping filing and packaging facility. ...
(Date:5/23/2013)... de mayo de 2013  Volcano Corporation (NASDAQ: ... fabricante de herramientas de precisión para terapia guiadas ... la enfermedad vascular periférica y coronaria, anunció hoy ... enosine V asodilator I ndependent ... sesión de ensayo clínico hot line late breaking ...
(Date:5/23/2013)... WASHINGTON , May 23, 2013 Hearing health ... active, feel younger, and remain socially and professionally engaged, he ... is the overriding message that the Better Hearing Institute ... support of National Men,s Health Week , which leads ... Health Week runs from June 10 through June 16. ...
Breaking Medicine Technology:Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4
... DIEGO, March 31, 2011 Accumetrics, Inc., developer of ... system for measuring platelet reactivity to multiple antiplatelet agents, ... testing has been incorporated into the updated 2011 ACCF/AHA ... The Guidelines, published online in the Journal ...
... Calif., March 31, 2011 NewCardio, Inc., (OTC Bulletin ... developer, announced today that the Company has been invited ... performance study at an upcoming conference entitled "Cardiovascular Safety ... Food and Drug Administration (FDA), the Cardiac Safety Research ...
Cached Medicine Technology:2011 ACCF/AHA Guidelines Incorporate New Recommendation for Platelet Reactivity Testing 22011 ACCF/AHA Guidelines Incorporate New Recommendation for Platelet Reactivity Testing 3NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 2NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 3NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 4NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 5NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 6
(Date:5/24/2013)... 24 (HealthDay News) -- People with high levels of ... die of liver disease than those with lower levels, ... cadmium in urine is evidence of long-term exposure to ... and tobacco smoke, the Johns Hopkins researchers explained. ... cadmium directly causes liver disease but instead suggest an ...
(Date:5/24/2013)... 6Webs.com has educated thousands of buyers on what ... monitoring provider. The easy to read reviews and ... prefer for unbiased and impartial home security reviews. 6Webs.com ... wireless home security system providers in the nation. The ... of key factors including reliability, technology and equipment. ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 According to a ... Facebook: Social Media Leads to Spikes in Plastic Surgery ... is a growing prevalence of facial plastic surgery ... These people have become keenly aware of the need to ... such as Facebook, Google and even Skype's video chat feature ...
(Date:5/24/2013)... BEACH, CA (PRWEB) May 24, 2013 ... health care education community, proudly participated in festivities surrounding ... April 19-21. The event provided the perfect backdrop to ... facilities at 236 E. 3rd Street, housed in an ... Arts Building. , ACC was an active exhibitor throughout ...
(Date:5/24/2013)... May 24 (HealthDay News) -- The number of ... after spending time in an emergency room has ... research. The study, conducted by researchers at ... and Health Services in Washington, D.C., found that ... on average before being admitted to the ICU. ...
Breaking Medicine News(10 mins):Health News:High Cadmium Levels May Raise Risk for Dying From Liver Disease: Study 2Health News:2013 Best Wireless Security System Providers Reported by 6Webs.com 2Health News:Facebook and Google – Is Social Media Driving Demand for Plastic Surgery? 2Health News:American Career College Revs Up Community Support During Toyota Grand Prix of Long Beach 2Health News:Sharp Rise in ICU Admissions From U.S. Emergency Rooms 2
... ... ... guru. And he’s not selling a philosophy, a religion, or telling you how to live. ... surrounding this young Croatian have spawned hundreds of thousands all over Europe lining up hours to ...
... less likely than Caucasians and men to undergo bone ... is the conclusion of a new analysis published early ... the American Cancer Society. The study,s results indicate that ... in access to bone marrow transplantation and also that ...
... study authors say , SUNDAY, May 23 (HealthDay News) ... face double the risk of becoming infected themselves when ... finding is slated for presentation Sunday at the International ... launched in Botswana, Kenya, Rwanda, South Africa, Tanzania, Uganda ...
... , ... Essence of Innovation and Survival , ... Placentia, CA (Vocus) May 23, 2010 -- Xlibris, the world’s leading print-on-demand self-publishing services ... the deck of creativity and innovation, a new book authored by Ralph M. Frid, Ph.D., ...
... New ... ... and interested individuals are in for an informative read as author Jerrold E. Kemp releases, ... book will help readers achieve a healthy long life., , ,Live Healthy At Any Age ...
... ... at The Balancing Act discovered that killing nasty germs has just become a ... run around with a can of disinfectant spraying everything is sight. Let’s ... Act, along with special guest Dr. Bob Arnot Thursday, May 27th at 7:00am ...
Cached Medicine News:Health News:Regular Guy "Braco" Healing Masses in Europe 2Health News:African-Americans and women are less likely to undergo bone marrow transplantation 2Health News:Female-to-Male HIV Transmission Risk Doubles During Pregnancy 2Health News:Xlibris Releases Trumping the Red Queen 2Health News:Xlibris Releases Trumping the Red Queen 3Health News:The Secret on How to Live Healthy at Any Age 2Health News:O2 Media's Hit Morning Show ‘The Balancing Act' Welcomes Dr. Bob Arnot to the Program 2
The Skull Pins are inserted into the receptacles of the Skull Clamp and fixate the head during surgery....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
Mayfield radiolucent skull clamp....
... for general applications and are equipped with our ... i.e. rigid endoscopes, range between 1 mm and ... to a 120 retrospection, and image angles ranging ... Endoscopes with working lengths of 1.5 meters and ...
Medicine Products: